600056 Stock Overview
Engages in the pharmaceutical business in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
China Meheco Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥10.69 |
| 52 Week High | CN¥14.20 |
| 52 Week Low | CN¥9.78 |
| Beta | 0.099 |
| 1 Month Change | -4.98% |
| 3 Month Change | -5.40% |
| 1 Year Change | -21.22% |
| 3 Year Change | 16.74% |
| 5 Year Change | 9.64% |
| Change since IPO | 489.99% |
Recent News & Updates
Insufficient Growth At China Meheco Group Co., Ltd. (SHSE:600056) Hampers Share Price
May 28
China Meheco Group's (SHSE:600056) Shareholders May Want To Dig Deeper Than Statutory Profit
May 06A Look At The Intrinsic Value Of China Meheco Group Co., Ltd. (SHSE:600056)
Apr 25Recent updates
Insufficient Growth At China Meheco Group Co., Ltd. (SHSE:600056) Hampers Share Price
May 28China Meheco Group's (SHSE:600056) Shareholders May Want To Dig Deeper Than Statutory Profit
May 06A Look At The Intrinsic Value Of China Meheco Group Co., Ltd. (SHSE:600056)
Apr 25Does China Meheco Group (SHSE:600056) Have A Healthy Balance Sheet?
Mar 28Shareholder Returns
| 600056 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | -0.4% | -1.2% | -0.07% |
| 1Y | -21.2% | -33.7% | -15.5% |
Return vs Industry: 600056 exceeded the CN Healthcare industry which returned -33.7% over the past year.
Return vs Market: 600056 underperformed the CN Market which returned -15.5% over the past year.
Price Volatility
| 600056 volatility | |
|---|---|
| 600056 Average Weekly Movement | 2.8% |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 10.2% |
| 10% least volatile stocks in CN Market | 4.1% |
Stable Share Price: 600056 has not had significant price volatility in the past 3 months.
Volatility Over Time: 600056's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 8,389 | Huidong Hu | www.meheco.com |
China Meheco Group Co., Ltd. engages in the pharmaceutical business in China and internationally. The company exports and imports natural medicines, pharmaceutical chemicals, medical equipment, and health products; produces and distributes pharmaceutical and health care products; and operates retail chain pharmacies. Its products include bulk pharmaceutical chemicals antibiotic fermentation and chemical synthesis tablets, injections, capsules, etc.; antibiotics; medicines for the treatment of cardio-cerebrovascular diseases, chronic diseases, and diabetes; antiviral; anti-infectious agents; gastrointestinal drugs; non-steroidal anti-inflammatory drugs; anti-allergic agents; specialty botanicals; western medicine preparations; Chinese patent medicines and herbal pieces; medical equipment and supplies; biological products; chemical raw materials; and nutritional and healthcare products.
China Meheco Group Co., Ltd. Fundamentals Summary
| 600056 fundamental statistics | |
|---|---|
| Market cap | CN¥15.92b |
| Earnings (TTM) | CN¥924.87m |
| Revenue (TTM) | CN¥35.07b |
17.3x
P/E Ratio0.5x
P/S RatioIs 600056 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600056 income statement (TTM) | |
|---|---|
| Revenue | CN¥35.07b |
| Cost of Revenue | CN¥31.04b |
| Gross Profit | CN¥4.02b |
| Other Expenses | CN¥3.10b |
| Earnings | CN¥924.87m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.62 |
| Gross Margin | 11.48% |
| Net Profit Margin | 2.64% |
| Debt/Equity Ratio | 39.0% |
How did 600056 perform over the long term?
See historical performance and comparison